mRNA-1273.351

N/A

Report date: 2026/05/13 11:17:53

Base Information

Drug NamemRNA-1273.351
Drug Alias NamemRNA-1273.351
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Multiple MyelomaImmunoglobulin Light-chain Amyloidosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesModerna Inc
China Registration ClassN/A

Develop Information

Active CompaniesModerna IncBarbara Ann Karmanos Cancer InstituteNational Institute Of Allergy And Infectious Diseases (Niaid)
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Multiple MyelomaImmunoglobulin Light-chain Amyloidosis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A